Reportable Segment and Major Customers Information - Pre-tax Earnings Table (Detail) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Operating (loss) income | $ (28,115) | $ 20,283 |
| Corporate expenses | (36,693) | (4,571) |
| Interest income | 3 | 1 |
| Interest expense | (148) | (372) |
| Other, net | (837) | (161) |
| Consolidated earnings (loss) before income taxes | (29,097) | 19,751 |
| Operating Segments [Member] | ||
| Total operating income | 8,578 | 24,854 |
| Operating Segments [Member] | Diagnostics [Member] | ||
| Operating (loss) income | 3,160 | (1,763) |
| Operating Segments [Member] | Life Science [Member] | ||
| Operating (loss) income | 5,383 | 26,602 |
| Eliminations [Member] | ||
| Operating (loss) income | $ 35 | $ 15 |
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Corporate expenses. No definition available.
|
| X | ||||||||||
- Definition Operating income attributable to segments. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|